Who better identifies significant liver fibrosis, MAFLD or MASLD, needs more rigorous, in-depth study

Hepatol Int. 2024 Sep 24. doi: 10.1007/s12072-024-10726-x. Online ahead of print.

Authors

Haoxuan Zou¹, Xiaobin Sun²

Affiliations

¹ Department of Gastroenterology and Hepatology, The Third People's Hospital of Chengdu, The Affiliated Hospital of Southwest Jiaotong University, Chengdu, 610031, Sichuan, China.
² Department of Gastroenterology and Hepatology, The Third People's Hospital of Chengdu, The Affiliated Hospital of Southwest Jiaotong University, Chengdu, 610031, Sichuan, China. xbsun1197@163.com.

PMID: 39317869
DOI: 10.1007/s12072-024-10726-x

No abstract available

Publication types

Letter